Staburo GmbH 10 year anniversary summer party

Staburo GmbH 10 year anniversary summer party

Staburo GmbH 10 year anniversary summer party

To celebrate the 10th anniversary of Staburo GmbH, we organised a summer party. It was a great pleasure to spend this special day with almost 120 people – employees & their families, friends, and other companions.

Even though the weather was unfortunately not so good, we had a nice barbecue & ice-cream, special Staburator beer – served in Staburo mugs, tattoos, tasty cocktails, and great live music. We really enjoyed spending time together again! Some moments were also captured in the PhotoBox. These pictures now decorate our office and remind us daily of this wonderful evening!

Data analysis, clinical biostatistics and more.

Staburo contributed to publication to assess Roche Elecsys® Anti-SARS-CoV-2 S assay

Staburo contributed to publication to assess Roche Elecsys® Anti-SARS-CoV-2 S assay

Staburo contributed to publication to assess Roche Elecsys® Anti-SARS-CoV-2 S assay

Staburo supported an exploratory analysis of the mRNA-1273 Phase 1 Trial to assess the clinical utility of the quantitative Roche Elecsys® Anti-SARS-CoV-2 S assay (ACOV2S). Geometric mean concentrations as well as seroconversion over time was assessed overall and by dose and age group.

Antibodies were detectable already at the first time point of assessment. All participants had seroconverted at the time point of the second assessment.

The paper was recently published in Frontiers in Immunology: https://doi.org/10.3389/fimmu.2021.798117

Staburo’s contribution is mentioned in the acknowledgements.

Data analysis, clinical biostatistics and more.

Meet the Management – Janine Roy – Director Bioinformatics and Data analytics

Meet the Management – Janine Roy – Director Bioinformatics and Data analytics

Meet the Management – Dr. Janine Roy – Director Bioinformatics and Data analytics

Since our team grew substantially, we searched, appointed, and enabled a bigger management team at Staburo, consisting of two heads (of departments) and six directors (focus on data science topics). Here, we want to give them a chance to talk about themselves and their passion! Therefore, we publish a mini news series about the management team members and will continue with our director director bioinformatics and data analytics, Dr. Janine Roy.

Who are you?

I am Janine Roy, director bioinformatics and data analytics at Staburo. I am a trained bioinformatician. I got my diploma from University of Jena and then moved to Dresden to do my PhD and post-doc at the Centre of Biotechnology (BIOTEC).

Tell me something about your area of expertise.

I support costumers in a range of tasks, mainly associated with transcriptomics data – starting from QC of raw data, over creating count matrices and finding differentially expressed genes, as well as interpreting them in a biological context.

Additionally, I am also involved in writing official reports. All this in the context of GCP.

I have a profound knowledge of programming R, bash, and Linux, as these are the essential tools that I use.

What are your goals for your role?

As Staburo started as a statistical consulting company, I like the idea of expanding the scope of the company. With the new field of bioinformatics, we now cover the whole range of data analysis in the clinical context from transcriptomics raw data to significantly deregulated genes, their biological interpretation and later helping our customers to present these results to the authorities for market access (e.g., G-BA, EMA/FDA).

What motivates you as an individual?

I always wanted to have an impact on human life. Therefore, I chose to do my PhD in Dresden, where I worked on improving cancer outcome prediction by integrating network information into transcriptomics data analysis. During my post-doc I was able to improve my knowledge working with human NGS data due to close collaboration of my former PI and university clinics. This intention still drives me today!

What would you like to share about your personality that you believe it is useful for your role?

As the position requires a lot of communication with costumers (e.g., PIs, technicians, statisticians, medical writers) and colleagues it is quite helpful that I am a proactive and outgoing person.

Data analysis, clinical biostatistics and more.

ADAC first aid course with Springer Medizin

ADAC first aid course with Springer Medizin

ADAC first aid course with Springer Medicine publishing

Nine Staburo colleagues recently took part in a full-day first aid course that was organized in collaboration with the company Springer Medicine publishing, who is a neighbor company in our Munich office building.

The course was performed by ADAC, and contained goals and ideal steps for first aid situations, which can occur at work, but also in private life. It was great that theory and practical parts, e.g. cardiopulmonary resuscitation or wound care, were equally distributed. Especially interesting was the part about automatic external defibrillator (AED) function and use. A big thanks to Springer Medicine publishing, who offered that we can use one of their AEDs in emergency situations.

We are very happy that so many volunteers joined to offer a safe work environment at Staburo and be able to act correctly and fast, if there are any health issues at our workplace.

Data analysis, clinical biostatistics and more.

Staburo presents two posters @ PSI conference in Gothenburg

Staburo presents two posters @ PSI conference in Gothenburg

Staburo presents two posters @ PSI conference in Gothenburg

Two posters by Staburo members were presented at the PSI 2022 conference in Gothenburg, Sweden. The conference, regarded as the principal annual event of the statisticians in the pharmaceutical industry, took place as face-to-face event from 12th to 15th of June in the Gothia Towers.

High quality talks and poster presentations were accompanied by great social events and many opportunities to connect with colleagues.

The first poster was about a simulation study comparing different variance estimators and stratum weights in a Z-test for Kaplan-Meier rates at a fixed time. It was presented by Stephan Bischofberger, Biostatistician/Statistical Programmer, and it was based on joint work by Hannes Buchner, Gabriele Bleckert and Ling Zhu, as well as Rainer-Georg Göldner from Boehringer Ingelheim Pharma GmbH & Co. KG and Bernhard Haller from TUM. This poster also won a poster award at the conference!

The second poster was a collaboration by Laura Schlieker, Director Biostatistics at Staburo GmbH, and Anke Schulz, Principal Statistician at Bayer AG, comparing different cut off determination methods based on real study data from a phase III oncology trial, as well as using simulated data. Laura had the opportunity to present the poster to the audience in a 1-min poster pitch!

The conference Gala Dinner on the waterside in Gothenburg provided delicious food and great entertainment by an Abba tribute band and a DJ, made all PSI conference attendees celebrate until the early morning.

Data analysis, clinical biostatistics and more.

Staburo @ TUM career lounge

Staburo @ TUM career lounge

Staburo @ TUM career lounge

The TUM career day panel with the topic leadership was supported by Josef Höfler and other panelists (i.e., Susanne Keller from Baxter, Niklas Grünbauer from TenneT TSO, Bernd Kohler from Takeda and Herbert Reiter from financial.com)

During a panel discussion students had the opportunity to ask questions, e.g.:

  • How do I get a position as team leader?
  • How can I prepare for this position?
  • What kind of skills do I need?
  • What difficult situations came up and how did you handle them?

Josef Höfler shared his experience with the students from his perspective as entrepreneur.  Staburo started as small team and now has grown to over 55 employees. Especially in a constantly changing environment it is important to take over responsibilities. Creating an environment based on trust, clear communication, appreciation, and common goals is key for a successful company growth.

Data analysis, clinical biostatistics and more.